| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 07/14/2010 | CN101774978A Preparation method of linezolid and intermediate thereof |
| 07/14/2010 | CN101774977A Synthesis method of timolol maleate intermediates |
| 07/13/2010 | US7754886 N-acylsulfonamide apoptosis promoters |
| 07/13/2010 | US7754747 such as ({6-[2-(2-naphthylmethyl)-1,3-oxazol-5-yl]-2-naphthyl}oxy)acetic acid, used to modulate plasminogen activator inhibitor (PAI-1) gene expression and to treat PAI-1 related disorders; cardiovascular and respiratory disorders; fibrosis, polycystic ovary syndrome, Alzheimer's disease, or cancer |
| 07/13/2010 | CA2432211C Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient |
| 07/13/2010 | CA2304970C Method and reagents for n-alkylating ureides |
| 07/08/2010 | WO2010078333A2 Benzoxazole-based fluorescent metal ion indicators |
| 07/08/2010 | WO2010077068A2 Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same |
| 07/08/2010 | US20100173961 Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors |
| 07/08/2010 | US20100173933 Antibacterial agents |
| 07/07/2010 | CN101768130A Derivatives containing aminomethyl-5-membered aromatic heterocycle-4-carboxylic acid, preparation method, drug combination and application thereof |
| 07/07/2010 | CN101298442B Acidamide compound based on 2-(2'-hydroxyphenyl) benzoxazole, preparation and use thereof |
| 07/06/2010 | US7750165 crystal structure; bioavailability |
| 07/06/2010 | US7750164 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 07/06/2010 | US7750021 3-{[2-(2-Trifluoromethyl-biphenyl-4-yl)-benzo[b]thiophen-5-ylmethyl]-amino}-propionic acid, useful in the treatment or prevention diseases associated with endothelial differentiation, G-protein-coupled (EDG) receptor mediated signal transduction, such as acute or chronic transplant rejection |
| 07/06/2010 | US7750013 N-oxides as prodrugs of piperazine and piperidine derivatives |
| 07/06/2010 | US7749615 organoaluminum complex of an oxyphenylbenzoxazole; utilizing phosphorescence which emits light efficiently with high luminance and driving stability; high efficiency and durability; flat panel displays |
| 07/01/2010 | WO2010074776A2 Compounds for the treatment of cancer |
| 07/01/2010 | WO2010073078A2 Heterocyclic compounds as hdac inhibitors |
| 07/01/2010 | WO2010021693A3 Mif modulators |
| 07/01/2010 | US20100168164 Antidiabetic Oxazolidinediones and Thiazolidinediones |
| 07/01/2010 | CA2728118A1 Compounds for treatment of cancer |
| 06/30/2010 | EP2202216A1 Spiro-ring compound and use thereof for medical purposes |
| 06/29/2010 | US7745470 N-((1R,2S)-3-(3,5-difluorophenyl)-1-hydroxy-1-((2R,4R)-4-propoxypyrrolidin-2-yl)propan-2-yl)-3-((R)-2-(methoxymethyl)pyrrolidine-1-carbonyl)-5-(oxazol-2-yl)benzamide, used to prevent the accumulation of amyloid protein deposits in the brain; treatment of Alzheimer's disease and Down's Syndrome |
| 06/29/2010 | CA2373530C Taxane derivatives and processes for the preparation thereof |
| 06/24/2010 | WO2010031835A3 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| 06/24/2010 | WO2008096372A3 Process for preparing highly pure ezetimibe using novel intermediates |
| 06/24/2010 | US20100160397 Oxazole derivatives and their use in the treatment of diabetes and obesity |
| 06/24/2010 | US20100160357 Heterobicyclic sphingosine 1-phosphate analogs |
| 06/24/2010 | US20100160313 Discovery of novel anticancer compounds based on conformational sampling of quinoxalinhydrazide pharmacophore |
| 06/24/2010 | US20100158996 Ester compound and medical use thereof |
| 06/23/2010 | EP1646629B1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 06/23/2010 | CN101747287A 2-oxo-1,3-O-aza-cyclopentane-4-carboxamide derivative and application thereof in preparation of immunosuppressant |
| 06/23/2010 | CN101072762B Phenyl-piperazin methanone derivatives |
| 06/22/2010 | US7741327 Pyrrolidinone glucokinase activators |
| 06/22/2010 | US7741316 Pharmacological uses of azetidine derivatives |
| 06/22/2010 | US7740074 Tree mounted well flow interface device |
| 06/22/2010 | CA2444198C Nociceptin analogs |
| 06/22/2010 | CA2420996C Substituted heterocyclic compounds for treating multidrug resistance |
| 06/22/2010 | CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 06/22/2010 | CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 06/22/2010 | CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 06/17/2010 | WO2010066682A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 06/17/2010 | WO2010066100A1 The 2-oxo-1,3-oxaazocyclopentane-4-formamide derivatives and their uses as the immunosuppressant. |
| 06/17/2010 | WO2010048207A3 Aryl gpr120 receptor agonists and uses thereof |
| 06/17/2010 | US20100152453 Novel Compounds and Preparation for Montelukast Sodium |
| 06/17/2010 | US20100152255 Organic Compounds |
| 06/17/2010 | US20100152185 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 06/17/2010 | DE102008062566A1 Aminosäureester-Prodrugs und ihre Verwendung Amino acid ester prodrugs and their use |
| 06/17/2010 | CA2745843A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 06/16/2010 | EP2196454A2 Exo-and diastereo-selective syntheses of himbacine analogs |
| 06/16/2010 | EP1651958B1 Novel chemiluminescent compounds and their use |
| 06/16/2010 | CN1989141B Bicyclic heterocycles as HIV integrase inhibitors |
| 06/16/2010 | CN101735057A Naphthyl carboxylic acid compounds with insulin-sensitizing activity and preparation method thereof |
| 06/16/2010 | CN101735048A Salicylic acid compounds with insulin-sensitizing activity and preparation method thereof |
| 06/15/2010 | US7737166 such as 2-tert-Butyl-7-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-5-methyl-6-phenyl-1,3-benzoxazole-4-carbonitrile hydrochloride, a 1,6-beta-glucan synthetase inhibitor having potent growth inhibition, used treating a fungal infections; fungicides |
| 06/15/2010 | CA2521647C Novel hydroxamates as therapeutic agents |
| 06/10/2010 | WO2010065512A2 Compounds for treating proliferative disorders |
| 06/10/2010 | WO2010064189A1 Regeneration of 2,2`-cyclopropylidene-bis(oxazolines) |
| 06/10/2010 | US20100145048 Compounds for the treatment of inflammatory disorders |
| 06/10/2010 | US20100144747 1h-quinaz0line-2,4-diones |
| 06/10/2010 | US20100144727 Oxazolidine and Morpholine Carboxamide Derivatives as P2X7 Modulators |
| 06/10/2010 | US20100143253 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 06/10/2010 | CA2745065A1 Compounds for treating proliferative disorders |
| 06/10/2010 | CA2744982A1 Regeneration of 2,2`-cyclopropylidene-bis(oxazolines) |
| 06/09/2010 | EP2193125A2 Oxadiazole derivatives |
| 06/09/2010 | EP2193118A2 Piperidine and piperazine derivatives for treating tumours |
| 06/09/2010 | EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis |
| 06/09/2010 | CN101723911A Method for synthesizing N-aryl-1,3-oxazolin-2-one compounds |
| 06/09/2010 | CN101721412A Methods of treating microbial infections in humans and animals |
| 06/08/2010 | US7732597 Prepared by acetylating (S)-N-[[3-[3-fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]amine in a solvent, optionally in presence of an organic base to form linezolid, seeding reaction mixture, and isolating linezolid form III; antibacterial agent; thermally stable |
| 06/08/2010 | US7732471 e.g. 2-Methyl-6-[3-(5-methyl-2-m-tolyloxazol-4-ylmethoxy)propoxymethyl]benzoic acid; peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonists/antagonists; insulin-related metabolic disorders of the blood such as hyperlipidemia, diabetes, insulin-resistance; atherosclerosis |
| 06/03/2010 | WO2010061366A1 Manufacture of bisoprolol and intermediates therefor |
| 06/03/2010 | WO2010030891A3 Aryl guanidine f1f0-atpase inhibitors and related methods |
| 06/03/2010 | US20100137605 Process for production of piperidine derivatives |
| 06/03/2010 | US20100137385 Insecticidal Substituted Amino Heterocyclic and Heteroaryl Derivatives |
| 06/03/2010 | US20100137349 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions |
| 06/03/2010 | US20100137323 Benzo-fused compounds for use in treating metabolic disorders |
| 06/03/2010 | US20100137298 Biaryl Sulfonamides and Methods for Using Same |
| 06/03/2010 | US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 06/03/2010 | US20100137243 Oxazolidinone And/Or Isoxazoline As Antibacterial Agents |
| 06/03/2010 | US20100136024 Selective Inhibition of Histone Deacetylase 6 for Ocular Neuroprotection or for Treatment or Control of Glaucoma |
| 06/02/2010 | EP1658263B1 Novel aminobenzophenone compounds |
| 06/02/2010 | EP1517881B1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 06/02/2010 | EP1483228B1 Nk1 antagonists |
| 06/02/2010 | EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance |
| 06/02/2010 | CN101717374A Compound comprising fork biphenyl center and preparation method thereof |
| 06/01/2010 | US7728027 reacting 2-bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone with 1-(tert-butoxycarbonyl)-L-proline, then treating the product with ammonium acetate and deprotection to form chemical intermediates for viricides; cost efficiency; industrial scale |
| 06/01/2010 | US7728020 such as 3-amino-5-(4-heptyloxy-phenyl)-3-methyl-pentanoic acid, useful in the treatment and/or prevention of diseases or disorders mediated by lymphocytes interactions e.g. in transplant rejection and autoimmune diseases |
| 06/01/2010 | US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 06/01/2010 | US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/27/2010 | WO2010058995A1 Electroluminescent device using the electroluminescent compounds |
| 05/27/2010 | WO2010058206A1 Method for making phenylethylamine compounds |
| 05/27/2010 | US20100130747 Oxazolidinium Compounds and Use as Hydrate Inhibitors |
| 05/27/2010 | US20100130737 Regulating Agent of GPR34 Receptor Function |
| 05/27/2010 | US20100130556 Ep2 receptor agonists |
| 05/27/2010 | US20100130495 Compounds 563 |
| 05/27/2010 | US20100130484 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors |
| 05/27/2010 | CA2744198A1 Method for making pharmaceutical compounds |
| 05/26/2010 | EP2188270A2 Preparation of a compound for the treatment of duchenne muscular dystrophy |